计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| O413862-1mg |
1mg |
现货 ![]() |
| |
| O413862-5mg |
5mg |
现货 ![]() |
| |
| O413862-10mg |
10mg |
现货 ![]() |
| |
| O413862-25mg |
25mg |
期货 ![]() |
|
| 英文别名 | ONO-WG-307(S)-9-(1-acryloylpiperidin-3-yl)-6-amino-7-(4-phenoxyphenyl)-7H-purin-8(9H)-one |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | ONO-4059 analogue |
| 生化机理 | ONO-4059 类似物(ONO-WG-307)是 ONO-4059 的类似物,它是一种高效、选择性口服 BTK 抑制剂,IC50 为 23.9 nM。第一阶段 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
Information ONO-4059 analogue ONO-4059 analogue (ONO-WG-307) is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1. Targets BTK 23.9 nM In vitro In TMD-8 cells, ONO-4059 inhibits cell growth with IC50 of 3.59 nM, and induces cell apoptosis. The combination of of ONO-4059 with doxorubicin, etoposide, vincristine or dexamethasone causes the increased apoptosis ratio. |
| 纯度 | ≥98% |
| ALogP | 3.38 |
|---|---|
| HBD Count | 1 |
| Rotatable Bond | 5 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 6-amino-7-(4-phenoxyphenyl)-9-[(3S)-1-prop-2-enoylpiperidin-3-yl]purin-8-one |
| INCHI | 1S/C25H24N6O3/c1-2-21(32)29-14-6-7-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-10-12-20(13-11-17)34-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m0/s1 |
| InChi Key | KSUDUUBCXJUFRL-SFHVURJKSA-N |
| Smiles | C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N |
| Isomeric SMILES | C=CC(=O)N1CCC[C@@H](C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N |
| PubChem CID | 89455219 |
| 分子量 | 456.5 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 20 mg/mL warmed with 50ºC Water: bath (43.81 mM); Ethanol: 3 mg/mL warmed with 50ºC Water: bath (6.57 mM); Water: Insoluble; |
|---|---|
| DMSO(mg / mL) Max Solubility | 20 |
| DMSO(mM) Max Solubility | 43.81161008 |
| Water(mg / mL) Max Solubility | <1 |
| 分子量 | 456.500 g/mol |
| XLogP3 | 2.900 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 6 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 456.191 Da |
| 单同位素质量Monoisotopic Mass | 456.191 Da |
| 拓扑极表面积Topological Polar Surface Area | 105.000 Ų |
| 重原子数Heavy Atom Count | 34 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 751.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
¥720.90